AssureMDx analyzes DNA from exfoliated urothelial cells in urine to identify mutations (FGFR3, TERT, HRAS) and methylation changes (OTX1, ONECUT2, TWIST1), allowing for highly accurate detection of bladder cancer. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.